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Abstract 
ATF4 is a transcription factor that is activated in response to integrated stress response (ISR). 
In neurons specifically, ATF4 has been suggested to act as a pro-apoptotic transcription 
factor. The expression of ATF4, as well as its downstream gene targets have been implicated 
in both in vivo and in vitro models of Alzheimer’s and Parkinson’s Disease. However, the 
mechanism by which ATF4 promotes cell death remains unclear. It was previously shown 
that overexpression of ATF4 in primary cortical neurons caused a reduction in glutathione 
levels, resulting in oxidative stress-induced cell death. The aim of this project was to 
investigate whether endogenous upregulation of ATF4 during ER-stress-induced activation 
of the ISR affects GSH levels and neuronal survival, and to identify factors that might 
mediate this response. Our results showed that in the presence of ER stress, WT cells 
possibly degrade GSH more rapidly compared to ATF4-deficient neurons, however, they 
compensate for this by increasing the rate of GSH de novo synthesis and maintain higher 
levels of GSH. Our findings also showed that the ATF4-dependent cell death observed in TG 
treated neurons is not induced by oxidative stress and cannot be ameliorated by the addition 
of antioxidants. Finally, we suggest that the underlying reason behind our differential 
observation regarding GSH consumption in overexpression and endogenous ISR activation 
pathways, is due to context dependent induction of different ATF4 target genes.  
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Chapter 1  
1 Introduction  
1.1 Oxidative stress: The balance between free radicals 
and antioxidants   
1.1.1 Free Radical  
Oxidative stress is a result of an imbalance between the rate of free radical production 
and clearance. Free radicals are molecular species with one or more unpaired electrons 
that are unstable and highly reactive. Some of these are generated due to inefficiencies in 
biological systems, such as superoxide anion radical (O2
•-), which is produced by the 
leakage of electrons from the electron transport chain during mitochondrial respiration 
(Cadenas & Davies, 2000). The superoxide anion can dismutate to form hydrogen 
peroxide (H2O2), which cannot react directly with nucleic acids, lipids and most proteins 
(Halliwell, 2001). In high concentrations however, H2O2 can further react through the 
Fenton reaction to form hydroxyl radical (HO•), which is considered to be the most 
reactive radical in the body and unlike superoxide, it cannot be eliminated through 
enzymatic reactions (Bogaerts, Theuns & van Broeckhoven, 2008). The hydroxyl radical 
can attack purine and pyrimidine bases in DNA, amino acid residues in proteins and it 
can oxidize lipids, leading to lipid peroxidation (Halliwell, 2001) (Figure 1.1). Other 
times, free radicals are produced to serve a useful purpose in the cell, such as nitric oxide 
(NO), which acts as a signalling molecule. NO in the brain is generated by neuronal nitric 
oxide synthase (nNOS), generally in response to N-methyl-D-aspartate (NMDA) receptor 
activation and contributes to neuronal plasticity (Bredt, 2003). However, during 
pathological conditions, overactivation of NMDA receptors can lead to excessive 
production of NO (Girouard et al, 2009). NO can react with superoxide anion radicals to 
form peroxynitrite (ONOO͘•), a powerful oxidant, which has the ability to damage cellular 
components such as DNA, lipids and proteins (Halliwell, 2001) (Figure 1.1). There are 
various processes in the brain that contribute to the production of free radicals. These 
include the extensive use of glutamate as a neurotransmitter in neurons, auto-oxidation of 
neurotransmitters such as dopamine as well as the high oxygen consumption of neurons 
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through the mitochondrial electron transport chain, to keep up with the energy demand of 
neurons (Halliwell, 2001). Excessive production of free radicals is a contributing factor in 
the progression and pathogenesis of neurodegenerative diseases. For instance, a decrease 
in complex I activity of the mitochondria has been shown to be one of the earliest events 
in the pathogenesis of Parkinson’s disease (PD) (Hwang, 2013). Inhibition of complex I 
leads to increased production of free radicals, which can cause further damage to the 
mitochondria and other cellular compartments (Halliwell, 2001). Similarly, mitochondrial 
dysfunction and increased ROS production have been implicated in Alzheimer’s disease 
(AD) (Swerdlow, Burns & Khan, 2015).    
1.1.2 Antioxidants  
Considering that free radical production happens naturally in vivo, there are antioxidant 
defense systems in place to counterbalance their effects and to prevent damage to cellular 
components. Antioxidants can be broadly classified into two classes: enzymatic and non-
enzymatic.  
1.1.2.1 Superoxide dismutases (SODs)  
Superoxide dismutases (SODs) are one of the important classes of enzymatic antioxidants 
that catalyze the dismutation of the superoxide anion into hydrogen peroxide. In 
eukaryotic cells, there are three forms of SOD (Fattman, Schaefer & Oury, 2003). The 
first is the copper/zinc SOD (SOD1) that binds both copper and zinc, and is located 
mainly in the cytosol, nucleus, lysosomes, peroxisomes and the intermembrane space of 
mitochondria (Valentine, Doucette & Potter, 2005). Mutations in the sod1 gene account 
for 20-25% of familial forms of amyotrophic lateral sclerosis (fALS), which makes it the 
most common cause of inherited ALS (Valentine, Doucette & Potter, 2005). Previous 
studies have shown that transgenic mice overexpressing Cu/Zn SOD show attenuated 
neuronal damage following traumatic brain injury (TBI) (Mikawa et al, 1996). 
Furthermore, it has been shown that reduction in Cu/Zn SOD worsens outcome after 
transient focal ischemia (Kondo et al, 1997).   
The manganese SOD (SOD2) is another important member of this family. As the name 
suggests, Mn-SOD binds manganese and is found in the mitochondrial matrix. Mice 
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lacking this enzyme die several days after birth due to severe oxidative damage to the 
mitochondria in metabolically active cells including cardiomyocytes and neurons 
(Lebovits et al, 1996).   
In addition to intracellular SODs, there is an extracellular SOD (EC-SOD) that is the 
third member of the SOD family and it is secreted to the extracellular matrix. The role of 
EC-SOD is not yet fully understood but is thought to prevent formation of peroxynitrite 
(ONOO-), which is a toxic product of the reaction between O2
•- and NO (Fattman, 
Chaefer, & Oury, 2003). Previous research suggests that mice deficient in EC-SOD 
develop normally, however, they seem to be more sensitive to hyperoxia (Carlsson, 
Jonsson, Edlund, & Marklund, 1995) and show a significantly greater volume of cerebral 
infarct after middle cerebral artery occlusion (MCAo) (Sheng, Brady, Pearlstein, Crapo & 
Warner, 1999).  
SODs are an important part of the antioxidant defense system since they are considered to 
be the first line of defense against superoxide anions. The final product that is produced 
by all forms of SODs is H2O2.  
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Figure 1.1. Free radical production in neurons. In the process of electron transport in 
the mitochondria, electrons can leak at complex I and III, allowing them to interact with 
oxygen (Perier & Villa, 2012). Partial reduction of O2 leads to the formation of 
superoxide anion radicals (O2
•-). O2
•- can react with NO produced by nNOS through the 
activation of NMDA receptor to form peroxynitrite or can be reduced to hydrogen 
peroxide by the action of SODs. Hydrogen peroxide can either be reduced to water 
through the action of catalase or glutathione peroxidase (GPx), or it can form hydroxyl 
radicals. Both peroxynitrite and hydroxyl radicals are capable of damaging cellular 
macromolecules. 
5 
 
1.1.2.2 Glutathione system  
Hydrogen peroxide can be reduced to water through the enzymatic action of different 
enzymes including catalase and glutathione peroxidase (GPx). The relative abundance of 
these two enzymes vary from one tissue to another. For example, GPx activity is higher 
in the brain compared to catalase, while in the liver both enzymes are equally abundant 
(Maher, 2005). Furthermore, GPx is present in the mitochondria and is important for 
reducing H2O2 produced in the mitochondria (Maher, 2005). GPxs also function to reduce 
lipid hydroperoxides to their corresponding alcohols. In humans, GPxs exist in different 
forms. Among them, GPx1 is the most abundant and the best characterized. GPxs differ 
based on their localization, as well as their structure and their substrate affinity (Maher, 
2005). GPx1 for example, is present in the mitochondria and the cytoplasm of almost all 
tissues and its preferred substrate is hydrogen peroxide while GPx2 and 3 are highly 
expressed in the gastrointestinal tract and kidney respectively, with hydrogen peroxide as 
their preferred substrate as well (Maher, 2005). In contrast, GPx4 has a higher preference 
for lipid hydroperoxides and is expressed in almost all tissues at a lower level (Yant et al. 
2003). Previously, distribution of GPx1 has been mapped in the brain, showing 
predominant localization in activated microglia and astrocytes (Lindenau, Noack, 
Asayama & Wolf, 1998). Furthermore, it has been suggested that increased GPx activity 
modulates recovery of spatial memory after TBI (Tsuru-Aoyagi et al, 2009). GPxs use 
reduced glutathione (GSH) as a cofactor and an electron donor in the enzymatic reaction 
of reducing hydrogen and lipid peroxides. Glutathione-S-transferase (GST) is another 
enzyme whose activity is dependent on a steady supply of GSH. GST acts primarily to 
detoxify xenobiotics by catalyzing the nucleophilic attack of GSH on electrophilic 
centers of a wide variety of substrates to prevent them from attacking crucial cell 
components such as proteins, lipids and nucleic acids (Hayes, Flanagan & Jowsey, 2005). 
Glutathione itself can also react non-enzymatically (through H transfer) with a wide 
variety of radicals such as OH•, OCH3
•, OOH•, and is therefore considered to be an 
excellent free radical scavenger (Galano & Alvarez-Idaboy, 2011). Furthermore, GSH is 
particularly effective against toxic species such as peroxynitrite and seems to be the only 
known compound that is capable of scavenging hydroxyl radicals, making it one of the 
most important antioxidants in the cell (Maher, 2005). In fact, data from primary cortical 
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neurons show that depletion of GSH sensitizes neurons to oxidative stress-induced cell 
death (Baxter et al, 2015).  
GSH is a tripeptide that is composed of glutamate, glycine and cysteine. Generally, 
intracellular cysteine level is the limiting factor for synthesis of GSH since glutamate and 
glycine are present at relatively high concentrations in most cells (Maher, 2005). 
Evidence from rat primary cortical neurons suggests that addition of N-Acetyl-L-
Cysteine (NAC) supplement, which is a precursor for GSH synthesis, to the cultures 
increases neuronal GSH levels (Dringen & Hamprecht, 1999).  Further evidence that 
points to the importance of cysteine as a rate-limiting precursor for synthesis of GSH 
comes from a study done in malnourished children, which showed that their low levels of 
GSH was caused by impaired GSH synthesis that was associated with lower 
concentrations of cysteine (Reid et al, 2000). A follow up study by the same group later, 
showed that NAC supplementation increased GSH synthesis rate and concentration 
(Badaloo, Reid, Forrester, Heird & Jahoor, 2002). The majority of intracellular cysteine 
comes from reduction of cystine that is imported into the cell by the glutamate/ cystine 
antiporter, system xc
- (xCT), which imports one molecule of cystine in exchange for one 
molecule of glutamate (Maher, 2005). System xc
- is composed of xCT also known as 
SlC7A11, the system’s light chain, which is the catalytic subunit and confers substrate 
specificity and 4F2hc, the system’s heavy chain, which is the chaperone that recruits 
SlC7A11 to the plasma membrane (Koppula, Zhang, Shi, Li & Gan, 2017; Maher, 2005). 
The expression of this transporter in the cells therefore helps in maintaining intracellular 
GSH levels and protecting cells from oxidative stress by providing the limiting precursor 
for GSH synthesis (Lim & Donaldson, 2011). Some reports suggest that neurons are 
unable to take up cystine directly and therefore rely on astrocytes to provide them with 
GSH precursor, cysteine (Sagara, Miura & Bannai, 1993). This reliance on astrocytes is 
due to their enhanced ability to take up cystine as a monomer to synthesize GSH. 
Astrocytes then release large amounts of GSH into the extracellular space, which is 
broken down, producing glycine and cysteine that can be taken up by neurons (Bélanger, 
Allaman & Magistretti, 2011). There are other reports however, that suggest that neurons, 
astrocytes and microglia all express system xc
- and are capable of importing cystine 
(Jackman, Uliasz, Hewett & Hewett, 2015). It has been shown that the ectopic expression 
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of the SLC7A11, the key component of system xc
-, increases GSH biosynthesis in cancer 
cells (Clemons, Liu, Duong & Phillips, 2017). Once cystine is taken up by the cells, it is 
reduced to cysteine and can be used as a precursor for biosynthesis of GSH. The thiol 
group of the cysteine moiety acts as a reducing agent by donating electrons to other 
molecules such as ROS to neutralize them (Wu, Fang, Yang, Lupton & Turner, 2004).  
GSH is synthesized in the cytoplasm in a two-step reaction, each catalyzed by a specific 
enzyme. The first step is the formation of γ-glutamylcysteine from glutamate and 
cysteine and is catalyzed by γ-glutamylcysteine ligase (GCL). In the second step, γ-
glutamylcysteine then reacts with glycine in a reaction catalyzed by glutathione 
synthetase (GS) to synthesize GSH (Lu, 2013). It has been shown that the first step of 
GSH synthesis is the rate limiting step since overexpression of GCL but not GS leads to 
an increase in GSH levels (Grant, MacIver & Dawes, 1997). Although most of the GSH 
remains in the cytoplasm, where it was synthesized, some of it is distributed to other 
organelles such as endoplasmic reticulum (ER), mitochondria and nucleus, where it 
serves its antioxidant function (Marí, Morales, Colell, García-Ruiz & Fernández-Checa, 
2009).  
Once GSH reacts either enzymatically or non-enzymatically with free radicals, it is 
oxidized to GSH disulfide (GSSG), and can only go back to its reduced form by the help 
of the enzyme glutathione reductase (GR) and NADPH as a reducing agent (Figure 1.2). 
The main source of NADPH in the cells is the pentose phosphate pathway (PPP), which 
is an alternative branch of glycolysis (Maher, 2005). Although this pathway does not 
produce energy in the form of ATP, it is important for producing sugars that are used for 
synthesizing DNA and RNA and also for producing NADPH, which is essential for 
regeneration of GSH. It has been shown previously that the rate of glycolysis in neurons 
is lower than in astrocytes because of the lower activity of PFK2, an enzyme encoded by 
pfkfb3 that is responsible for generation of fructose-2,6-bisphosphate (F2,6P2) in neurons 
(Almeida, Almeida, Bolaños & Moncada, 2001; Almeida, Moncada & Bolaños, 2003). It 
has also been shown that increasing the rate of glycolysis by overexpressing pfkfb3 in 
neurons causes rapid neuronal apoptosis possibly due to a decrease in utilization of 
glucose through the PPP and consequently, a decrease in regeneration of GSH (Herrero-
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Mendez, Almeida, Fernández, Maestre, Moncada & Bolaños, 2009). This suggests that 
regeneration of GSH from its oxidized form is an important mechanism for keeping the 
GSH pool in cells. The ratio between GSH and GSSG is an important indicator of the 
redox status of the cell, with lower ratios being correlated to higher susceptibility of the 
cells to oxidative stress (Ballatori, Krance, Notenboom, Shi, Tieu & Hammond, 2009).  
 All these antioxidant defense mechanisms have evolved to protect cells and tissues from 
free radical attack. There is a controlled balance between the rate of free radical 
production and its clearance by antioxidants. Any disturbance to this system that causes 
an imbalance can lead to oxidative stress, which can cause damage to macromolecules 
and lead to oxidative stress-induced cell death.  
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Figure 1.2. Glutathione system. Glutathione is synthesized in a 2-step reaction and is 
composed of cysteine, glutamate and glycine. Cysteine is the limiting precursor for 
synthesis of GSH that comes from the reduction of cystine that is imported into the cell 
by a cystine/glutamate antiporter. The first step of GSH synthesis is the rate limiting step 
that is catalyzed by enzyme glutamylcysteine ligase (GCL). Once GSH is synthesized in 
the cytosol, it can be transported to other organelles such as mitochondria, ER and 
nucleus. GSH can react non-enzymatically with a wide range of ROS in the cell. It can 
also act as an electron donor in an enzymatic reaction with GPx and GST. Once GSH 
acts enzymatically or non-enzymatically with free radicals, it is oxidized to GSSG and 
can only go back to its reduced form with the help of GR and NADPH. 
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1.2 Oxidative stress and neurodegeneration 
Although all tissues can undergo oxidative damage, the brain is particularly susceptible 
due to its relatively lower enzymatic antioxidant activity, and also due to its high oxygen 
consumption demand. The brain makes up about 2% of the body weight, but it accounts 
for 20% of basal oxygen consumption (Uttara, Singh, Zamboni & Mahajan, 2009). This 
high demand for oxygen is to meet the metabolic needs of neurons in terms of ATP 
production required for signaling and action potential propagation. This also means that 
in order to meet this high energy demand, mitochondrial activity is of utmost importance 
in these cells. One consequence of high levels of mitochondrial respiration is an increase 
in the rate of free radical production by the mitochondria. Furthermore, with glutamate 
being the most abundant excitatory neurotransmitter in the brain, there is an increased 
rate of NO production due to activation of nNOS. In addition to this, resident microglia in 
the brain generate free radical species such as O2
-, H2O2 and NO (Halliwell, 2001). 
Additionally, the fact that neurons are post-mitotic and cannot regenerate themselves 
makes them susceptible to oxidative stress-induced neurodegeneration due to 
accumulation of oxidative damage over time.  
1.2.1 Aging and oxidative damage 
An increase in mitochondrial dysfunction and oxidative damage has been seen in aging 
and age- related neurodegenerative diseases (Cassarino, & Bennett, 1999). Aging has 
long been correlated with the accumulation of oxidative damage to cellular 
macromolecules. Numerous studies have shown that levels of DNA damage (both 
mitochondrial and nuclear) and lipid peroxidation are increased with aging (Liu & Xu, 
2011). The accumulation of oxidative damage over years can also modify the activity and 
structure of certain proteins, causing a variety of age-related diseases (Ethen, Reilly, 
Feng, Olsen & Ferrington, 2007; Machado, Ayala, Gordillo, Revilla & Santa Maria, 
1991). Oxidative damage has been shown to increase with age in various organisms 
including mice, flies and C-elegans (Liu & Xu, 2011). Various animal and human studies 
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suggest that GSH concentration declines with age, largely because of diminished supply 
of its precursors such as cysteine (Sekhar et al, 2011). Furthermore, data from Drosophila 
melanogaster suggests that NAC supplementation slows down aging and increases 
lifespan (Brack, Bechter-Thüring & Labuhn, 1997). Considering that oxidative damage is 
an important factor in aging, it is not surprising to see it as a hallmark of various age 
related neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s 
disease (PD).    
1.2.2 Alzheimer’s disease 
Alzheimer’s disease is a progressive neurodegenerative disorder and is the most common 
form of dementia, affecting predominantly individuals over the age of 65. Although 
different risk factors have been identified for this disease, aging remains the most 
important. AD is characterized by aggregation of extracellular amyloid plaques and 
intracellular neurofibrillary tangles (Tönnies, & Trushina, 2017). However, the 
underlying cause of the disease remains to be elucidated. There are various hypotheses 
regarding the disease mechanism and progression, which suggest that oxidative stress 
could either be the cause or the consequence of Aβ deposition (Du, Wang & Geng, 2018). 
Many studies have shown that protein oxidation and lipid peroxidation are increased in 
the brains of patients with AD (Hensley et al, 1995; Palmer & Burns, 1994; Marcus et al, 
1998). Additionally, peroxynitrite, a potent oxidant that is formed by the reaction of 
superoxide with nitric oxide, is elevated in brains of AD patients, specifically, within the 
neurofibrillary tangles, further highlighting the importance of oxidative stress in the 
pathology of AD (Good, Werner, Hsu, Olanow & Perl, 1996; Smith, Richey Harris, 
Sayre, Beckman & Perry, 1997). Lipid peroxidation has also been shown to be the major 
cause of membrane phospholipid depletion in AD (Prasad, Lovell, Yatin, Dhillon & 
Markesbery, 1998). Clinically, GSH measurement using magnetic resonance 
spectroscopy in AD patients and healthy controls has shown GSH levels to be 
significantly decreased in both males and females with AD (Mandal, Tripathi & Sugunan, 
2012). Furthermore, both in vivo and in vitro studies in mice report an AD-associated 
GSH decrease, suggesting that the increase in the ROS level is partly due to a decrease in 
the level of antioxidants (Resende et al, 2008; Ghosh, LeVault, Barnett & Brewer, 2012). 
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Post mortem brain tissues from AD patients also show that there is a decrease in 
GSH/GSSG ratio (Ansari & Scheff, 2010). Interestingly, the reduction of cellular 
GSH/GSSG ratio is shown to correlate with the activation of caspases and the loss of 
anti-apoptotic protein Bcl2 (Filomeni, Rotilio & Ciriolo, 2003). There is a great body of 
research investigating the therapeutic potential of antioxidants in AD. One example is 
NAC that has been investigated as a potential therapeutic agent. NAC is also able to 
protect against Aβ induced protein oxidation and lipid peroxidation. Furthermore, it can 
enhance the activity of GPx and GR that has been diminished in APP/PS-1 knock-in mice 
(Huang et al, 2010). These data highlight the role of oxidative stress in the progression of 
AD as well as the role of antioxidant defense in delaying and ameliorating AD 
symptoms.   
1.2.3 Parkinson’s disease  
Another neurodegenerative disease that is associated with oxidative stress is Parkinson’s 
disease (PD). PD is characterized by the selective loss of dopaminergic (DA) neurons of 
the substantia nigra (SN) and abnormal aggregation of alpha-synuclein protein known as 
Lewy bodies (Hauser & Hastings, 2013). Both in vivo and in vitro models of PD report 
mitochondrial dysfunction, specifically, a decrease in complex I activity, to be one of the 
earliest events in the pathogenesis of the disease (Hwang, 2013). Previous studies have 
shown that drugs such as MPP+ and Rotenone inhibit complex I of the mitochondrial 
respiratory chain and cause an increase in the amount of superoxide produced by 
complex I (Langston, Forno, Rebert & Irwin, 1984; Betarbet, Sherer, MacKenzie, Garcia-
Osuna, Panov & Greenamyre, 2000). Blocking mitochondrial complex I using rotenone 
in mice caused selective degeneration of nigrostriatal dopaminergic neurons that was 
accompanied by behavioral and neurological features of PD (Betarbet et al, 2000). Recent 
work suggests that one of the reasons why nigral DA neurons are highly vulnerable in PD 
is due to their specific morphological and bioenergetic characteristics. These data suggest 
that this particular population of neurons has a higher rate of mitochondrial oxidative 
phosphorylation (OXPHOS) and a higher density of axonal mitochondria as well as 
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increased basal level of oxidative stress, all due to their highly complex axonal 
arborization (Pacelli, Giguère, Bourque, Lévesque, Slack & Trudeau, 2015). The 
mitochondrial dysfunction alone however, does not explain the selective degeneration of 
the specific cell types in the SN. Another factor that may play a role in increasing the 
vulnerability of these cells to oxidative stress is the metabolism of DA itself. Although 
DA is usually stored in vesicles, excess cytosolic dopamine can be oxidized to form 
dopamine quinones (DAQ) (Hwang, 2013). DAQs can covalently react with low 
molecular weight thiols such as GSH and protein cysteinyl residues, which can have 
adverse effects on cellular function and health (Hauser & Hastings, 2013). Additionally, 
DAQs can also make highly reactive species known as aminochromes that can generate 
superoxide anions and deplete cellular NADPH, the essential precursor for regeneration 
of GSH (Hwang, 2013). Post mortem analyses have shown that there is a significant loss 
of GSH and a decrease in GSH/GSSG ratio in the substantia nigra of patients with PD 
(Dexter et al, 1994; Sian et al, 1994). Although this is not thought to be the cause of PD, 
it is considered to be an early event in the progression of the disease, which makes cells 
more susceptible to ROS attack and oxidative damage (Jenner, 1994).   
1.2.4 Stroke  
Increases in ROS and oxidative stress have also been seen in conditions such as ischemic 
stroke (Chan, 2001). The neuronal damage caused by ischemia is due to interruption of 
blood flow, hypoxia, ATP depletion and the reperfusion that follows. Under hypoxic 
conditions, oxygen is depleted and the cell switches to glycolysis where ATP can be 
produced anaerobically. In this pathway, lactate and H+ accumulate in the mitochondria 
and result in acidosis. Acidosis contributes to ROS formation since H+ can enhance the 
conversion of O2
•- to H2O2 and consequently HO
• (Shirley, Ord & Work, 2014). 
Reperfusion has also been shown to have deleterious effects on the brain since it causes a 
rapid increase in ROS production by the mitochondria (Chouchani et al, 2015). NADPH 
oxidase (NOX) is one of the enzymes that is thought to be the main source of ROS 
production after ischemia/reperfusion injury (McCann, Dusting & Roulston, 2008). 
Previous studies have shown that inhibition of NOX reduces the oxidative stress and 
infarct volume as well as the post-ischemic inflammation in the brain (Chen, Song & 
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Chan, 2009; Chen, Kim, Okami, Narasimhan & Chan, 2011). Different strategies have 
been explored to lower ROS levels after stroke in order to manage and reduce the extent 
of injury. Free radical scavengers such as lipoic acid and NAC have shown promising 
results by reducing lesion volume significantly (Clark, Rinker, Lessov, Lowery & 
Cipolla, 2001; Khan et al, 2004). In fact, several compounds with antioxidant capacity 
have been developed, some of which progressed to clinical trials and even to the market. 
For example, Edaravone is a free radical scavenger that showed promising results in rats 
with focal ischemia and is now used in some countries as a therapy for stroke recovery 
(Amemiya et al, 2005; Miyaji et al, 2015). These results highlight the importance of ROS 
production in pathogenesis of ischemic stroke and reperfusion.   
Overall, it has been well established that disruption of the homeostatic balance between 
the production and clearance of free radicals in the brain can sensitize neurons to 
oxidative stress and have irreversible consequences. Considering the post-mitotic nature 
of neurons, prompt and efficient action of antioxidants is therefore of utmost importance 
for the survival of these cells. Despite the knowledge about the involvement of oxidative 
damage in different neurodegenerative diseases the mechanisms underlying antioxidant 
depletion is not fully understood.   
1.3 The role of integrated stress response during cellular 
stress  
The integrated stress response (ISR) is an evolutionarily conserved adaptive pathway that 
is activated in response to cellular stress and acts to ameliorate the disturbance and 
restore homeostasis. In addition to oxidative stress, there are various stressors that can 
activate the ISR pathway including amino acid deprivation, endoplasmic reticulum (ER) 
stress, hypoxia, heme deprivation, viral infection, etc. Each of these stressors may 
activate one or more of the four different kinases involved in the ISR: GCN2, PKR, HRI 
and PERK. Activation of each of these kinases leads to phosphorylation of the alpha 
subunit of the eukaryotic initiation factor 2, eIF2α (Pakos‐Zebrucka, Koryga, Mnich, 
Ljujic, Samali & Gorman, 2016). eIF2 is a heterotrimer that is composed of an alpha, a 
beta and a gamma subunit (Kimball, 1999). Phosphorylation of eIF2α under stress 
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condition leads to general inhibition of protein translation, which acts to conserve energy 
and nutrients and to provide a temporary relief from the stress (Harding, Zhang, 
Bertolotti, Zeng & Ron, 2000; Lu et al, 2004). Under normal conditions, GTP-bound 
eIF2 binds to tRNA carrying the first amino acid, methionine (Met-tRNAi), forming the 
ternary complex (TC). The TC then binds to the 40S ribosomal subunit, creating the 43S 
preinitiation complex (PIC). The PIC then binds to the mRNA that has already been 
unwound and starts searching along the mRNA for the start codon, AUG. Once AUG is 
paired with methionine, eIF5, which is a GTPase-activating protein is recruited to the 
complex, and it induces GTP to be hydrolyzed to GDP. This hydrolysis allows for the 
40S ribosomal subunit to be dissociated from the complex, bind to the 60S ribosomal 
subunit and initiate the protein translation. The GDP bound to eIF2 then needs to be 
exchanged for GTP to allow for another round of translation initiation, and this is done 
with the help of the guanine nucleotide exchange factor (GEF), eIF2B (Sonenberg & 
Hinnebusch, 2009). Figure 1.3 shows the schematic of translation initiation and the 
important players involved in the process. eIF2B has 5 different subunits, 2 of which are 
catalytic and the other 3 are regulatory subunits (Sidrauski et al, 2015). Once eIF2α is 
phosphorylated during stress conditions, its binding affinity for eIF2B increases and so 
acts as an inhibitor of the GEF (Krishnamoorthy, Pavitt, Zhang, Dever & Hinnebusch, 
2001). Since the cellular concentration of eIF2B is much lower than eIF2, its activity can 
be abolished even by a small amount of eIF2 phosphorylation. The inhibition of eIF2B 
renders the cell unable to re-initiate protein translation leading to a significant attenuation 
in the general protein synthesis, which acts to protect cells during acute stress (Sidrauski 
et al, 2015). Interestingly, there are certain proteins that are preferentially translated 
during this process, such as Activating Transcription Factor 4 (ATF4).  
 
 
 
16 
 
 
Figure 1.3. Integrated stress response (ISR) regulates translation initiation and 
allows for translation of ATF4. Under normal conditions, GTP-bound eIF2 binds to 
tRNA carrying methionine and forms the ternary complex (TC). The TC then binds to the 
40S ribosomal subunit and creates the preinitiation complex (PIC). PIC binds to the 
mRNA and starts scanning through the length of it to find the start codon, AUG. Once 
methionine is paired with AUG, eIF5 is recruited to hydrolyze GTP to GDP and allow the 
dissociation of the complex from the 40S ribosomal subunit. The 40S ribosomal subunit 
can then bind to 60S subunit and initiate translation initiation. In order for another round 
of translation initiation to begin, the GDP bound to eIF2 needs to be exchanged for GTP, 
and this is done with the help of guanine nucleotide exchange factor, called eIF2B. eIF2B 
has a higher affinity for phosphorylated eIF2. Therefore, under stress conditions when the 
alpha subunit of eIF2 is phosphorylated by different kinases, it acts as an inhibitor of 
eIF2B, rendering the cell unable to reinitiate protein synthesis, leading to inhibition of 
general protein translation. During this process, certain proteins such as ATF4 are 
preferentially translated.   
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1.3.1 Activating Transcription Factor 4 
ATF4, also known as cAMP- response element binding protein 2 (CREB-2) is a basic 
leucine zipper (bZIP) transcription factor, which can homo- or heterodimerize with other 
bZIP transcription factors through the leucine zipper region. The basic region is upstream 
of the leucine zipper, which contains positively charged amino acids that function as the 
DNA-binding domain (Vallejo, Ron, Miller & Habener, 1993; Karpinski, Morle, 
Huggenvik, Uhler, & Leiden, 1992). ATF4 can homo- or heterodimerize with other bZIP 
transcription factors, which includes three major subfamilies: cJun/cFos, ATF/CREB and 
CCAAT enhancer binding protein (C/EBP) (Wortel, van der Meer, Killberg & van 
Leeuwen, 2017). ATF4 also has other functional domains including the N-terminal 
domain, which contains a p300 interaction site. P300 is a histone acetyltransferase that 
acts as a transcriptional coactivator, by binding to transcription factors and regulating 
transcription initiation (Teufel, Freund, Bycroft & Fersht, 2007). It has been shown that 
p300 allows for stabilization of ATF4 by inhibiting ubiquitination and proteasomal 
degradation of the protein, which is independent of its acetyltransferase activity (Lassot, 
Estrabaud, Emiliani, Benkirane, Benarouse & Margottin-Goguet, 2005). Other 
domains/motifs that are present on the ATF4 protein and affect its stability are an 
oxygen-dependent degradation domain that is recognized by PHD3 and a β-TrCP 
recognition motif, which is targeted for proteasomal degradation (Figure 1.4) 
(Scortegagna et al, 2014; Lassot et al, 2001).  ATF4 exists as a monomer in the absence 
of a DNA target. In the presence of a DNA target, it can form homodimers on the DNA 
that are of low relative stability (Podust, Krezel & Kim, 2000). On the other hand, ATF4 
can also form heterodimers, which are more stable and bind to the DNA with higher 
affinity (Podust, Krezel & Kim, 2000). This protein is an integral part of the ISR and acts 
as an effector element by transcriptionally regulating the expression of different genes. 
The main hypothesis regarding the expression of ATF4 protein is that the ATF4 mRNA is 
preferentially translated in response to eIF2α phosphorylation because of the contribution 
of the two upstream open reading frames (uORFs) in the 5’ region of its mRNA. 
Normally, once the proximal uORF (uORF1) has been translated, GDP is exchanged for 
GTP, allowing the eIF2-TC complex to be reacquired and the translation to be reinitiated 
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at uORF2. The second uORF is inhibitory, thereby reducing the expression of ATF4 
protein. Under stress conditions where eIF2-GTP levels are low, translation initiation is 
delayed, causing the 40S ribosome to scan through the inhibitory subunit, allowing ATF4 
to be expressed (Vattem & Wek, 2004).  
Although ATF4 is expressed in many cell types and is an important part of the cells’ 
stress response, its role in the embryonic development and differentiation of osteoblasts 
has also been investigated thoroughly. Consequently, it has been found that ATF4-
deficient mice tend to have delayed bone formation and a reduced bone mass (Yang et al, 
2004). ATF4 deficiency also causes microphthalmia, highlighting the importance of the 
protein in the formation of lens fibres and the anterior lens epithelial cells during 
development (Tanaka et al, 1998; Hettmann, Barton & Leiden, 2000).  
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Figure 1.4. Functional domains of ATF4 protein. ATF4 protein has a leucine zipper 
domain on its C-terminal end, which is essential for heterodimerization with other bZIP 
transcription factors. Upstream of the leucine zipper, there is a basic domain that is 
important for DNA binding. There is also a β-TrCP recognition motif that is dependent 
on the phosphorylation events on ATF4. β-TrCP recognizes specific phosphorylated 
residues and targets the protein for proteasomal degradation. ATF4 protein stability is 
also affected by the oxygen-dependent degradation domain (ODDD), which is recognized 
by PHD3. Finally, there is a p300 interaction site at the N-terminal domain of the protein. 
P300 stabilized ATF4 protein by inhibiting ubiquitination and proteasomal degradation.     
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During stress conditions, ATF4 seems to play a dual role depending on the target genes it 
induces (Wortel, van der Meer, Killberg & van Leeuwen, 2017). ATF4 can translocate 
into the nucleus and regulate the expression of adaptive genes that are involved in amino 
acid transport and metabolism, oxidative stress and protein homeostasis to help relieve 
the stress (Harding et al, 2003). For example, ATF4 induces GADD34, which is 
important for initiating a negative feedback loop, dephosphorylating eIF2α and restoring 
protein translation (Ma & Hendershot, 2003). It can also induce genes that are important 
for cell survival such as Grp78/BiP, which encode ER chaperone proteins to enhance 
protein folding (Luo, Baumeister, Yang, Abcouwer & Lee, 2003). However, if the stress 
condition persists, and ATF4 upregulation is sustained, it can induce apoptosis and cell-
cycle arrest through the induction of pro-apoptotic genes such as CHOP (Zinszner et al, 
1998; Galehdar, Swan, Fuerth, Callaghan, Park & Cregan, 2010). In addition to the duration 
of stress, the effects of ATF4 seem to be cell type-dependent. In fibroblasts for instance, 
it has been shown that ATF4 deficient cells are impaired in activating genes that are 
important for protection against oxidative stress, while ATF4 deficient neurons seem to 
be protected against oxidative stress (Harding et al, 2003; Lange et al, 2008). This may be 
because certain pro-death genes such as Trib3 are induced by ATF4 under stress 
conditions in neurons but not in fibroblasts (Lange et al, 2008). Most of the literature in 
non-neuronal cells tends to emphasize the pro-survival role of ATF4, however, it is 
generally accepted that sustained activation of ATF4 can be detrimental for most cells. 
Another factor that may modulate specific gene transcription and affect the signalling 
outcome is the formation of heterodimers with different bZIP family members by ATF4. 
For example, interaction with ATF3 and CHOP has been shown to activate NOXA, a 
Bcl-2 homology3 (BH3)-only pro-apoptotic protein and Trib3, respectively (Wang et al, 
2009; Ohoka, Yoshii, Hattori, Onozaki & Hayashi, 2005). On the other hand, interaction 
with C/EBPγ is important for expression of stress-induced genes such as ChaC1, 
SlC7A11, ASNS and CTH, which are involved in oxidative homeostasis and amino acid 
biosynthesis and transport (Huggins et al, 2015). The effect of ATF4 activation is 
therefore highly context dependent. ATF4 can also undergo various post-translational 
modifications, which can affect the stability as well as the transcriptional activity of the 
protein. For instance, post-translational stabilization, using the proteasome inhibitor 
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MG132 has been shown to be an effective method for expression of ATF4 protein 
(Milani et al, 2009). Other examples of post-translational modifications include 
phosphorylation of ATF4 at specific threonine residues (Thr107, Thr114, Thr5, Thr119), 
which destabilizes the protein and inhibits its transcriptional activation of PUMA and 
NOXA, both of which are important mediators of the pro-apoptotic response (Bagheri-
Yarmand et al, 2015). Additionally, methylation of ATF4 on arginine residue 239 has 
been shown to modulate its transcriptional properties (Yuniati et al, 2016).    
1.3.2 The role of ISR and ATF4 expression in neurons 
The role of ISR and ATF4 expression has been investigated in various neurodegenerative 
diseases as well as hypoxia, TBI and spinal cord injury. 
1.3.2.1 Alzheimer’s disease  
Mounting evidence suggests that the ISR is activated in both in vivo and in vitro models 
of AD. Previously it has been shown that p-eIF2α is elevated in the hippocampus and the 
prefrontal cortex in the APP/PS1 AD mouse model (Ma et al, 2013). These results have 
also been confirmed by immunohistochemical studies of post mortem AD brains 
compared to their age-matched controls. In these studies, eIF2α staining was shown to be 
elevated in the cell bodies of hippocampal neurons of AD brains as compared to age-
matched control brains (Chang, Wong, Ng & Hugon, 2002). It has also been shown that 
treatment of rats’ primary cortical and hippocampal neurons with Aβ oligomer in vitro 
increases Trib3 mRNA and protein levels, which is a pro-apoptotic transcriptional target 
of ATF4 (Saleem & Biswas, 2016). These results were also confirmed in vivo by 
injecting Aβ oligomer directly into rat brain. Consequently, oligomeric Aβ has been 
shown to induce apoptosis both in vitro and in vivo (Saleem & Biswas, 2016). Deletion of 
PERK, an eIF2α kinase that has been implicated in AD, prevented Aβ-induced 
impairments in LTP as well as other AD associated abnormalities such as special 
memory deficits (Ma et al, 2013). But PERK does not seem to be the only eIF2α kinase 
that has been associated with AD. Immunohistochemical staining has shown that the AD 
brains also have a higher level of phosphorylated PKR in the degenerating neurons 
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(Chang, Wong, Ng & Hugon, 2002). Cellular models of AD have shown that ATF4 is 
synthesized axonally in response to Aβ treatment, which is in turn important for the 
retrograde transport and Aβ-induced neurodegeneration (Baleriola et al, 2014). 
Interestingly, recent data suggests that treating neurons with ISRIB, which has been 
shown to restore protein translation downstream of eIF2α, protect cells from Aβ-induced 
neuronal cell death (Halliday et al, 2015; Hosoi, Kakimoto, Tanaka, Nomura & Ozawa, 
2016).  
1.3.2.2 Parkinson’s disease  
Evidence suggests that in various cellular models of PD, such as the 6-OHDA and MPP+ 
paradigms, ER stress is induced, causing upregulation of ATF4 and CHOP expression 
(Ryu, Harding, Angelastro, Vitolo, Ron & Greene, 2002). It has also been shown that 
overexpression of ATF4 in rat SN in vivo significantly increases caspase 3/7 activity and 
reduces the percentage of tyrosine hydroxylase (TH)-positive cells (Gully et al, 2016). 
Moreover, the pro-apoptotic gene, Trib3, has been shown to be highly induced in 
response to 6-OHDA and MPP+ treatments in PC12 neuronal cells and that upregulation 
of Trib3 in PD paradigms promotes cell death (Rye, Angelastro & Greene, 2005; Aimé et 
al, 2015). Interestingly, Trib3 upregulation has also been observed in SN dopaminergic 
neurons in post-mortem tissue from human PD patients (Aimé et al, 2015).  
1.3.2.3 Stroke and spinal cord injury  
The role of ATF4 has also been investigated in models of ischemic and hemorrhagic 
stroke. In a study conducted by Lange and colleagues, it was demonstrated that ATF4 
deficient mice are less susceptible to ischemic brain damage, showing smaller infarct 
volumes and faster recovery after transient middle cerebral artery occlusion (MCAo) a 
model of ischemia-reperfusion injury (Lange et al, 2008). Interestingly, in another study 
published by the same group, it was shown that intraperitoneal administration of 
adaptaquin, a HIF-PHD inhibitor, in rats, prevented neuronal death in an intracerebral 
hemorrhage (ICH) stroke model and this was attributed to the suppression of ATF4 
mediated expression of pro-death genes (Karuppagounder et al, 2016). Involvement of 
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ATF4 has also been implicated in spinal cord injury (SCI). Evidence for this comes from 
a study which suggests that ATF4 binds directly to the promoter of the gene 
Zbtb38/CIBZ, which is involved in SCI (Cai et al, 2017; Cai, Li, Yang, Li, Zhang & Liu, 
2012). Furthermore, knockdown of ATF4 caused a decrease in the expression level of 
Zbtb38 (Cai et al, 2017).         
The involvement of ATF4 in neuronal apoptosis has also been investigated in cell-based 
models. ATF4 induction using the ER-stressor, thapsigargin, causes cell death through 
upregulation of PUMA, which is mediated by the induction of its proapoptotic target 
gene, CHOP (Galehdar et al, 2010). Cell-based models also show that restoration of 
protein synthesis downstream of eIF2α through treatment with ISRIB leads to a reduction 
in neurodegeneration induced by pathogenic prion protein in rats (Halliday et al, 2015). 
Moreover, previous data suggest that ectopic overexpression of ATF4 in primary cortical 
neurons causes a reduction in GSH levels and a consequent decrease in cell viability, 
which can be mitigated by the addition of other antioxidants such as butylated 
hydroxyanisole (BHA) (Lange et al, 2008).  
1.4 Rationale  
ATF4 is a stress-inducible protein that is upregulated in response to a variety of cellular 
stressors including ER-stress and oxidative stress. There have been various reports that 
have shown elevation of factors both upstream and downstream of ATF4, such as eIF2α 
phosphorylation and Trib3 induction in in vitro and in vivo models of AD and PD. We 
and others have demonstrated that prolonged activation of ATF4 promotes neuronal cell 
death, however, the mechanism behind it remains unclear. The importance of GSH as an 
antioxidant has been highlighted in other studies where its depletion has been shown to 
sensitize neurons to oxidative stress-induced cell death. Previously it was suggested that 
ectopic overexpression of ATF4 in primary cortical neurons leads to GSH depletion and 
neuronal cell death, which can be mitigated through the addition of antioxidants to the 
culture.  However, it remains unclear whether upregulation of endogenous ATF4 affects 
glutathione levels during neuronal stress.  
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1.5 Hypothesis 
Upregulation of endogenous ATF4 through the conventional pathway of ISR activation, 
depletes cellular GSH and sensitizes neurons to oxidative stress-induced cell death 
(Figure 1.5).  
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Figure 1.5. Rationale and hypothesis. Oxidative stress conditions can induce neuronal 
apoptosis through the induction of ISR and upregulation of ATF4. Glutathione depletion, 
which contributes to oxidative stress can also induce neuronal death. Recent evidence 
suggests that ATF4 might not only be the consequence of GSH depletion and oxidative 
stress but can even be a cause of it since its ectopic overexpression has shown to decrease 
GSH levels in neurons. In this project, we investigated the effect of endogenous ATF4 
upregulation on neuronal GSH levels, in order to establish a relationship between the 
two.  
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Chapter 2  
2 Materials and Methods 
2.1 Animals  
All animal procedures were carried out according to the protocols approved by the 
Animal Care Committee at University of Western Ontario. Mice carrying an ATF4-null 
mutation were obtained from Drs. Tim Townes and Joe Sun (University of Alabama at 
Birmingham, AL) (Masuoka & Townes, 2002). Wildtype and knockout littermates used 
for experimentation were generated by breeding heterozygous mice.  
2.1.1 Genotyping  
Genomic DNA was isolated using phenol/chloroform/isoamyl alcohol (Fisher 
Bioreagents®, FL-06-0205). The wildtype allele was detected using the primer 5’- 
AGCAAAACAAGACAGCAGCCACTA-3’, and the common reverse primer 5’- 
GTTTCTACAGCTTCCTCCACTCTT-3’.  The ATF4-knockout allele was detected 
using the primer 5’- ATATTGCTGAAGAGCTTGGCGGC-3’. PCR reagents (Taq 
polymerase, 10x buffer, 50 mM MgCl2, and Q Solution) were purchased from Qiagen 
(Toronto, ON - 201205). The dNTPs were purchased from Life Technologies (Burlington 
ON - 10297-018). The PCR cycling conditions were programmed as such: initial PCR 
activation step (95˚C, 2 min), cycling step (denaturation 94˚C, 20 sec; annealing 62˚C, 30 
sec; elongation 68˚C, 90 sec, x 30 cycles), followed by a final extension step (70˚C, 10 
mins). The samples were then cooled at 4˚C.  
2.2 Cell culture  
2.2.1 Primary cortical neurons 
Primary neuronal cultures were dissected from the cerebral cortices of embryonic mice 
day 14.5-15.5 (E14.5-15.5). Pregnant mice were euthanized with 700 mg/kg of sodium 
pentobarbital, injected intra-peritoneally prior to cervical dislocation. The cortices from 
27 
 
each embryo was stored and processed separately after the removal of the meninges. A 
tail sample of each embryo was also obtained separately for genotyping purposes.  
Immediately after dissection, the cortices were placed in 1×Hanks’ Balanced Salt 
Solution (HBSS; Gibco®, 14170-112) and kept on ice until processing time. To 
dissociate the cortical tissue, individual cortices were trypsinized with 1×HBSS solution 
supplemented with 1×trypsin (Sigma, T4549) as well as 1.2 mM MgSO4 and were placed 
in a 37˚C incubator for 25 minutes. The trypsin was then inhibited by the addition of 600 
µL of 1×HBSS supplemented with 1.2 mM MgSO4, 0.2 mg/mL trypsin inhibitor (Roche, 
10109878001) and 0.25 mg/mL DNase I. The samples were mixed thoroughly and 
centrifuged for 4 minutes at 400×g. After the centrifugation, the supernatant was 
removed, and the pellet was resuspended in 1 mL of 1×HBSS solution supplemented 
with 3 mM MgSO4, 0.8 mg/mL DNase I and 1.25 mg/mL trypsin inhibitor. To further 
dissociate the tissue, the pellets were triturated 10-15 times with a flame polished pipette. 
The samples were centrifuged one last time to pellet the cells and were resuspended in 2 
mL of complete neurobasal media (NBM; Gibco®, 21103-049) supplemented with 
0.5×B27 (Life Technologies, 17504044), 1×N2 (Life Technologies, 17502048), 
0.5×Glutamax (Life Technologies, 35050061) and 50 U/mL penicillin: 50 µg/mL 
streptomycin (Life Technologies, 15140-122).  
The cell suspension was diluted in supplemented NBM to a concentration of 6×105 
cells/mL and plated in either 35mm (2 mL; 1.2×106 cells/dish) or 4-well (500 µL; 3×105 
cells/well) dishes. The dishes (NunclonΔ Surface, Thermo Scientific) were pre-coated 
with poly-L-ornithine (Sigma, P4957) (diluted 1:10 in ddH2O) over night and rinsed with 
ddH2O. Cultures were maintained in a 37˚C incubator with 5% CO2 until ready for use.    
2.2.2 N2A Cell line  
N2A cells were used for overexpression experiments. The mouse neuroblastoma cell line 
was purchased from ATCC® (CCL-131™). Cells were maintained in complete growth 
media made up of 90% Minimum Essential Media (MEM; Gibco®, 11095-080), 10% 
Fetal Bovine Serum (FBS; Gibco®, A31607-01), 0.5% 50 U/mL penicillin: 50 µg/mL 
streptomycin and 0.02% Gentamicin (Sigma, G1272). Cells were grown in T75 flasks 
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(Thermo Scientific) and were passaged every 5 days at 1:50 dilution. For experiments, 
N2A cells were plated at 2×105 cells/well density in 6-well plates (Cellstar®, 657160) 
and were incubated at 37˚C with 5% CO2 overnight, to allow adherence to the bottom of 
the plate.  
2.2.3 Plasmid transfection  
Lipofectamine®2000 (Invitrogen, 11668-019) was used to transfect the N2A cells with 
2µg of the pGFP or pcDNA3-mATF4. The plasmids were first diluted to 0.1 µg/µl in 
DNase/RNase-free water. Plasmids (2µg) were then diluted in 180 µl of 1×Opti-MEM 
(Gibco®, 31985-070), bringing the volume to 200 µl. Lipofectamine was also diluted in 
1×Opti-MEM (4µl of lipofectamine in 200 µl of 1×Opti-MEM). The diluted 
lipofectamine was then mixed with diluted plasmid and incubated at room temperature 
for 30 minutes before being added to the cells. The transfection media stayed on the cells 
for 30-36 hours before the cells were harvested for RNA and protein.  
2.2.4 Drugs  
ER-stress was induced using Thapsigargin (TG) (T9033, Sigma). Stock was made by 
solubilizing the contents in DMSO to a concentration of 1mM. L-Buthionine sulfoximine 
(BSO) (B2515, Sigma) stocks were made in DMSO at 100mM concentration. 
Antioxidants N-Acetylcysteine (NAC) (A7250, Sigma) and Butylated hydroxyanisole 
(BHA) (B1253, Sigma) stocks were made in DMSO and ethanol at 200mM and 100mM, 
respectively. Finally, the proteasome inhibitor, MG132 (SML1135, Sigma), was 
solubilized in DMSO at 10mM concentration. All treatments were diluted to their final 
concentrations in media that the cells were plated in (supplemented NBM for PCNs and 
N2A growth media for N2A cells) before use.   
2.3 Protein extraction and quantification  
Following specified treatments, culture media was aspirated, cells were washed with 
1×PBS and lysed with RIPA (Sigma, R0278) supplemented with 1:100 protease inhibitor 
cocktail (Sigma, P8340) and 1:100 phosphatase inhibitor (Sigma, P5726). The lysis 
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buffer was added directly to each culture dish, cells were scraped off and transferred to 
1.5 mL microcentrifuge tubes and placed on ice for 30 minutes. The samples were then 
centrifuged at 12,000×g for 15 minutes at 4˚C. The supernatant from each sample was 
transferred to a new labeled tubed and stored in the -80˚C freezer.  
Protein concentration was determined by Pierce® BCA Protein Assay Kit (Thermo 
Scientific) according to manufacturer’s protocol. Absorbance (562 nm) of samples was 
measured using SpectraMax® M5 Multi-Mode Microplate Reader (Molecular Devices) 
and SoftMaxPro V5 (Molecular Devices) software. Based on the absorbance, a standard 
curve was generated, and the concentration of samples were calculated based on the 
standards.  
2.4 Glutathione assay  
Reduced glutathione (GSH) was measured using monochlorobimane (MCB; Thermo 
Scientific, M1381MP). Primary cortical neurons were plated at 3×105 cells/well density 
in 4-well dishes.  At the end of the indicated treatments, 200 µl of the media was 
removed from each well, leaving behind 300 µl. The MCB solubilized in DMSO 
(100mM) was further diluted in NBM and added to each well at a final concentration of 
50 µM. The plates were incubated at 37˚C for 60 minutes to allow conjugation of MCB. 
Cells were then washed twice with 1×PBS and were extracted for protein as described 
above. Once the protein was isolated, 50 µl of each sample was aliquoted to a 96-well 
plate and fluorescence was measured at λex:390 nm and λem: 478 nm in SpectraMax® M5 
Multi-Mode Microplate Reader. The remainder of the protein for each sample was used 
to determine total protein levels for normalization purposes. GSH values were reported as 
relative fluorescent units (RFU)/ug of protein.  
2.5 NADPH quantification 
High Sensitivity NADPH Quantification Fluorometric Assay Kit (Sigma, MAK216-1KT) 
was used to quantify NADPH levels in each sample. To collect protein sample for each 
treatment condition, we pooled two 35mm dishes and lysed them in extraction buffer 
provided in the kit. Protein was extracted as described previously. After the supernatant 
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was transferred to a new microcentrifuge tube, a 50µl aliquot was mixed with another 
30µl of extraction buffer and incubated at 60˚C for 30 minutes to degrade NADP+. The 
samples were then incubated on ice before being aliquoted to 96-well microplate reader 
plate (50µl/sample). The NADPH standards and the reaction mix were prepared per 
manufacturer’s instructions (Appendix A). A 100µl aliquot of the reaction mix was added 
to each well and the plate was incubated at room temperature for 60 minutes before the 
fluorescence was measured (λex=535/λem=587 nm) in the SpectraMax® M5 Multi-Mode 
Microplate Reader (Molecular Devices) and SoftMaxPro V5 (Molecular Devices) 
software. The concentration of NADPH was calculated based on the standard curve and 
the remainder of the protein sample was used to quantify protein concentration. NADPH 
levels were normalized to protein concentration for each sample.  
2.6 Mitochondrial ROS detection   
MitoSOX™ Red (Life Technologies, M36008) was used for staining and quantifying 
mitochondrial superoxide in neurons. Primary cortical neurons were plated at 3×105 
cells/well density in 4-well dishes.  At the end of the indicated treatments, 200 µl of the 
media was removed from each well, leaving behind 300 µl. MitoSOX™ Red (5mM) was 
diluted in NBM and was added to each well at a final concentration of 0.2 µM. Cells 
were incubated at 37˚C for 2 hours. Neurons were then washed twice with 1×PBS and 
fixed in 4% paraformaldehyde (containing 0.2% picric acid in 0.1M phosphate buffer, pH 
7.1) for 30 minutes, then washed with 1×PBS again and stained with Hoechst 33342 
(0.25µg/ml) dye. Cells were visualized under fluorescent microscope and images were 
captured using a CCD camera (Q-imaging, Burnaby, BC, Canada) and Northern Eclipse 
software (Empix imaging, Mississauga, ON, Canada). For each treatment, the total 
fluorescence of four different fields was measured separately and normalized to the 
number of the cells in each field. The average of the four fields was calculated and was 
considered as an “n” of one for each treatment.    
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2.7 Real time quantitative RT-PCR analysis   
RNA was isolated using TRIzol® Reagent (Invitrogen) following manufacturer’s 
protocol and the concentration was quantified on a NanoDrop1000 Spectrophotometer 
(Thermo Scientific). RT- PCR was performed with the Qaigen quantifest RT-PCR kit 
(Qiagen, 204154). All primers were purchased from Life Technologies, and the 
sequences are included in Appendix B. PCRs were carried out using CFX Connect™ 
Real Time System (BioRad, Mississauga, ON, Canada) and the RT-PCR cycling 
conditions were programmed as such: reverse transcription (50˚C, 10 min), initial PCR 
activation step (95˚C, 5 min), cycling step (denaturation 95˚C for 10 sec; annealing and 
elongation 60˚C for 30 sec, x 40 cycles), followed by a melting curve analysis to confirm 
the specificity of the primers. Changes in gene expression were determined using the 
∆(∆Ct) method with the ribosomal S12 transcript being used for normalization. Data is 
reported as fold increase in mRNA levels in treated samples relative to corresponding 
untreated control samples for each transcript. Comparison of transcript levels at the 
baseline between wildtype and ATF4-deficient neurons were reported as ∆Ct(target 
transcript- S12).     
2.8 Metabolic flux assay  
Oxygen consumption rate was measured using Extracellular Flux Analyzer (Seahorse 
Biosciences). Seahorse XFe24 tissue culture microplates (Agilent, 100777-004) were 
coated with poly-L-ornithine overnight and were rinsed with ddH2O prior to plating. 
Primary cortical neurons were seeded at a density of 2.5×105 cells/ well (250µl) and were 
kept in the 37˚C incubator for 5 days prior to assay. The day before the assay, the sensor 
cartridge was hydrated with calibrant media according to manufacturer’s protocol 
(Seahorse XFe FluxPak mini, 102342-100) and was incubated at 37˚C in a non-CO2 
incubator over-night.  On the day of the experiment, prior to running the assay, the cells 
were washed with assay media: Seahorse XF base medium (Agilent, 103334-100) 
supplemented with 15mM glucose, 2µM L-glutamine (Gibco®, 25030-081) and 2µM 
sodium pyruvate (Gibco®, 11360-070), pH was adjusted to 7.4 using 0.1 N NaOH) and 
plates were incubated in this media in 37˚C non-CO2 incubator for 45-60 minutes. 
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Oxygen consumption was sequentially measured under basal conditions, in the presence 
of 1µM oligomycin, to asses ATP production, after injection of FCCP (2µM), to measure 
maximal respiration and finally in the presence of mitochondrial inhibitors, rotenone and 
antimycin A (1µM) to measure non-mitochondrial respiration. All chemicals were 
purchased as a kit: Seahorse XF Cell Mito Stress Test Kit (Agilent, 103015-100), and 
were diluted in assay media (injection ports were loaded with 80µl of each treatment and 
the starting volume in each well was 500µl). Immediately after the assay, cells were 
visualized under the microscope to ensure viability. Cells were then lysed using RIPA 
lysis buffer and protein was extracted as described previously for normalization purposes.  
2.9 Cell death and survival assays  
Live/Dead™ Viability/Cytotoxicity Kit (Molecular Probes, L3224) was used to assess 
cell viability. Cells plated in 4-well dishes were loaded with calcein-AM (1µM) and 
ethidium homodimer-1 (3µM) and incubated at 37˚C for 10 minutes. Images were 
captured using a CCD camera (Q-imaging, Burnaby, BC, Canada) and Northern Eclipse 
software (Empix imaging, Mississauga, ON, Canada). Live cells were detected by the 
uptake of Calcein-AM (green fluorescence), while dead cells were highly permeable to 
ethidium homodimer-1 (red fluorescence). Four different fields were captured per well 
under each filter. Both live and dead cells were counted and averaged over four fields and 
survival was determined by the fraction of live to total cells.  
2.10 Fluorescent immunocytochemistry  
Primary cortical neurons were plated in 4-well dishes at a density of 3×105 cells/ well and 
were incubated in a 37˚C incubator for 5 days. Cultures were rinsed with 1×PBS and 
fixed in 4% paraformaldehyde (containing 0.2% picric acid in 0.1M phosphate buffer, pH 
7.1) for 30 minutes, then washed 3 times with 1×PBS again before additions of cold 
methanol to each well for permeabilization. After 5 minutes incubation with methanol, 
cells were rinsed with 1×PBS 3 times and incubated with blocking solution (2% BSA in 
1×TBST) for an hour at room temperature. Cultures were stained for MAP2 (Abcam, 
ab7513) (diluted 1:100 in blocking solution) overnight at 4˚C. Cells were once again 
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washed with 1×PBS and incubated with Alexa Fluor™ 555 goat anti chicken (Invitrogen, 
A21437) (diluted 1:100 in blocking solution) for 2 hours at room temperature. Cultures 
were counterstained with Hoechst 33342 (10ug/mL) dye (diluted 1:1000 in 1×PBS) and 
were imaged using Leica-TCS sp8.  
2.11 Western blot analysis  
Whole cell extracts (40 µg) were separated on 12% SDS-polyacrylamide gels and 
transferred onto nitrocellulose membranes. Blots were probed with primary antibodies 
(diluted 1:1000 in blocking solution: 5% milk in TBST) against ATF4 (Abcam, 
ab184909) and cyclophilin (Abcam, ab178397) as loading control overnight. Membranes 
were then washed with TBST buffer and probed with HRP secondary (BioRad, 170-
6515) diluted 1:10,000, and immunoreactive bands were visualized using Clarity™ 
Western ECL substrate (BioRad, 170-5061). Blots were quantified by normalizing ATF4 
bands to cyclophilin.  
2.12 Data analysis  
Data were reported as mean and standard error of the mean (SEM). The statistical 
difference between groups was determined using either ANOVA and post hoc Tukey test 
or t-test. Differences were considered statistically significant with p-value<0.05. In PCNs 
each n value represents the number of embryos of each genotype from at least two 
independent neuron cultures, while in N2As each n value represents an independently 
prepared cell plate from a newly passaged culture.  
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Chapter 3  
3 Results  
ATF4 protein is induced in response to various stressors including ER-stress, which 
activates a series of signals that comprise the unfolded protein response (UPR) (Harding 
et al, 2000). The UPR is meant to relieve cells from stress by downregulating protein 
translation, enhancing protein folding by increasing the expression of specific ER 
chaperons, and activating proteases to degrade misfolded proteins. Prolonged ER-stress 
however, can lead to activation of apoptotic cell death (Liu & Kaufman, 2003). In order 
to upregulate endogenous ATF4, cells were treated with thapsigargin (TG). TG can cause 
an increase in cytosolic calcium levels since it acts as a non-competitive inhibitor of ER 
calcium ATPase and blocks the ability of the cell to pump calcium into the ER, which is 
required for ER function, and can activate the UPR (Rogers, Inesi, Wade & Lederer, 
1995). We have shown previously that TG treatment induces a substantial increase in 
ATF4 protein levels, which can cause neuronal cell death. Consistent with this, we have 
shown that ATF4-deficient neurons are protected against ER-stress induced cell death 
(Galehdar, Swan, Fuerth, Callaghan, Park & Cregan, 2010). Therefore, in this study, we 
used TG-induced ER stress as a model of ATF4-dependent cell death.     
3.1 Primary cortical cultures from both wildtype and ATF4-
deficient mice are mainly neuronal  
Firstly, to confirm that our primary cortical cultures were healthy and were mainly 
neuronal, cultures were stained with microtubule-associate protein (MAP2) as a neuronal 
marker at 5 days in vitro (DIV). Nuclei were also identified using Hoechst stain. 
Immunostaining results showed that in both WT and ATF4-deficient cultures, more than 
90% of the cells were stained with MAP2 suggesting that both cultures are primarily 
neuronal (Figure 3.1).  
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Figure 3.1. Primary cortical cultures are mainly neuronal. WT and ATF4-deficient 
cortical cultures were stained with MAP2 at 5 DIV and images were taken using Leica 
TCS sp8. Fluorescent images showed that both ATF4+/+ and ATF4-/- cultures are healthy 
and are primarily neuronal. Images were taken at 40x magnification.  
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3.2 Wildtype neurons retain GSH more efficiently compared 
to ATF4-KO cells in the presence of ER-stress 
A previous study suggested that ectopic overexpression of ATF4 depletes GSH levels in 
cortical neurons (Lange et al, 2008), therefore we examined endogenously upregulated 
ATF4 effects on GSH levels. To address this, we extracted primary cortical neurons from 
wildtype and ATF4-deficient mice and allowed them to mature in culture for 5 days after 
plating. Neurons were treated with TG for 12 or 24 hours to induce ATF4 protein levels 
and GSH was measured using a Monochlorobimane (MCB) assay. Our results showed no 
difference in GSH levels between WT (n=15) and ATF4-deficient (n=15) neurons in 
untreated cultures. Furthermore, although TG treatment caused a reduction in GSH levels 
in both WT (12_hours: ns, 24_hours: ##p<0.01) and ATF4-deficient neurons (12_hours: 
#p<0.01, 24_hours: ####p<0.0001), the reduction was significantly greater in the absence 
of ATF4 at both 12 hours (WT: n=12, ATF4-KO: n=12) (***p <0.001) and 24 hours 
(WT: n=12, ATF4-KO: n=12) (**p <0.01) post-treatment (Figure 3.2). This suggests that 
endogenous ATF4 upregulation acts to sustain GSH levels during ER-stress.  
3.3 ATF4+/+ neurons consume GSH more rapidly compared 
to ATF4-deficient cells in the presence of ER-stress 
The steady state level of GSH in cells reflects relative levels of its de novo synthesis, 
utilization and regeneration. To narrow down the part of the pathway that is affected by 
ATF4, de novo synthesis of GSH was blocked using L-buthionine sulfoximine (BSO). 
BSO blocks the rate limiting step in GSH synthesis by inhibiting the enzyme 
glutamylcysteine ligase (GCL) (Drew & Minors, 1984). Therefore, GSH levels measured 
in the presence of BSO reflect reserved GSH and GSH regenerated by the reduction of 
oxidized GSH. Neurons were co-treated with TG to induce endogenous ATF4 protein 
expression. Interestingly, when GSH synthesis was inhibited, an opposite trend of GSH 
loss was observed compared to TG treated neurons alone (Figure 3.2), where after 24h of 
TG and BSO co-treatment, WT (n=9) cells exhibited lower levels of GSH compared to 
ATF4-KO (n=9) neurons (*p<0.05) (Figure 3.3a). This suggests that ATF4 promotes 
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GSH synthesis in stressed neurons, however, it would appear that ATF4 also induces a 
more rapid consumption of GSH compared to ATF4-deficient cells in the presence of 
ER-stress. To confirm that the observed results were the combined effect of TG and BSO 
and not BSO alone, the experiment was repeated in the presence of BSO only. Our results 
showed that under non-stressed conditions, after 12 (WT: n=4, KO: n= 5) and 24 (WT: 
n=9, KO: n=8) hours of BSO treatment, both WT and ATF4-KO neurons had the same 
level of GSH, highlighting the fact that the difference that was observed during ER-
stress, was due to the combined effect of TG-induced ATF4 induction and BSO (Figure 
3.3b). Next, we investigated two possible mechanisms to explain why WT neurons lose 
GSH more rapidly compared to ATF4-deficient neurons.  
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Figure 3.2. ATF4+/+ neurons retain GSH levels to a greater extent compared to 
ATF4-/- neurons after induction of prolonged ER-stress. Cortical neurons were 
extracted from E14.5-15.5 ATF4+/+ and ATF4-/- littermates. Cultures were treated with 
TG (1-µM) and GSH levels were measured at 12 and 24 hours by MCB assay. ER-stress 
reduced GSH levels in both WT (24_h: ##p<0.01) and ATF-/- (12_h: #p<0.01, 24_h: 
####p<0.001) neurons, but the reduction was more significant in ATF4-deficient cells at 
both 12 (***p<0.001) and 24 (**p<0.01) hours. # signifies comparison to the untreated 
(UT) control. n values: UT WT/KO (n=15); 12 & 24_h TG WT/KO (n=12). 
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Figure 3.3. Endogenous upregulation of ATF4 increases GSH consumption. Cortical 
neurons were extracted from E14.5-15.5 ATF4+/+ and ATF4-/- littermates. (a) cultures 
were co-treated with 100-µM BSO and 1-µM TG. GSH was measured 12 and 24 hours 
post treatment. After 24h of co-treatment with TG and BSO, ATF4-deficient neurons 
(n=9) had higher levels of GSH compared to the WT (n=9) cells (*p<0.05) (b) when 
cells were treated with BSO (100-µM) only, there was no difference between GSH levels 
at either of the timepoints. n values: UT WT/KO (n=13); 12h BSO WT (n=4), KO (n=5); 
24h BSO WT (n=9), KO (n=8). 
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3.4 GSH regeneration pathway is not affected by ATF4 in 
neurons   
We next examined whether the higher GSH reserve in ATF4-deficient neurons was 
related to a potential difference in GSH regeneration capacity. The two important factors 
that are required for GSH regeneration are glutathione reductase (GR), which is the 
enzyme responsible for reducing GSH from its oxidized form (GSSG), and NADPH, 
which is the essential reducing agent in this process.  In order to assess GSH regeneration 
capacity, we measured both GR transcript level as well as NADPH levels. To measure 
GR mRNA levels, cortical neurons were treated with TG and RNA was collected after 8 
hours and relative mRNA levels were determined by qRT-PCR. Our results show that 
ER-stress causes a downregulation in GR transcription compared to the control (WT: 
***p<0.001; KO: ***p<0.001), although this occurs in an ATF4-independent manner 
(Figure 3.4a). Furthermore, comparison of mRNA levels at the baseline between WT and 
ATF4-deficient cells showed no difference between the two genotypes (Figure 3.4b). We 
also measured NADPH levels at baseline and after treatment with TG. Results showed 
that although ER-stress caused a reduction in NADPH levels in both WT (n=4) and 
ATF4-KO (n=3) neurons compared to untreated controls, the percent reduction compared 
to baseline was not significantly different between the two genotypes (Figure 3.4c). 
Taken together, these results suggest that GSH regeneration capacity is not affected by 
ATF4 in cortical neurons.   
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Figure 3.4. GSH regeneration pathway is not affected by ATF4. PCN were extracted 
from E14.5-15.5 ATF4+/+ and ATF4-/- littermates. (a,b) Neurons (5 DIV) were treated 
with 1-µM TG for 8 hours and mRNA levels of GR was determined by qRT-PCR. TG 
treatment reduced GR mRNA levels compared to the control in both WT (***p<0.001) 
and ATF4-deficient (***p<0.001) neurons (n=4), although the reduction was independent 
of ATF4 (b) GR mRNA levels are not significantly different in untreated WT and ATF4-
deficient neurons (n=4). (c) Neurons were treated with 1-µM TG for 9 hours and NADPH 
levels were determined by quantitative fluorometric assay. TG treatment reduced 
NADPH levels compared to control in both WT (n=4) and ATF4-deficient (n=3) neurons 
in an ATF4-independent manner. 
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3.5 ATF4 does not affect mitochondrial ROS production   
In an effort to explain why WT neurons consume GSH more rapidly compared to ATF4-
deficient cells, we next investigated whether the level of oxidative processes differs 
between WT and ATF4-deficient neurons. To evaluate this, we quantified mitochondrial 
superoxide as a measure of ROS production in ATF4+/+ and ATF4-/- neurons. 
3.5.1 ER-stress affects mitochondrial bioenergetics in an ATF4-
independent manner  
In order to ensure that our treatment paradigm affects different aspects of mitochondrial 
respiration and that mitochondrial superoxide would be a reliable measure for ROS, we 
analyzed different aspects of mitochondrial respiration by measuring the oxygen 
consumption rate (OCR) of the cells under various conditions using Seahorse Mito Stress 
test. Results showed that TG treatment caused a reduction in basal respiration as well as 
ATP production, while it did not influence maximal respiration or spare respiratory 
capacity (Figure 3.5). However, the effect of TG on mitochondrial bioenergetics was not 
ATF4-dependent. These results imply that mitochondrial superoxide can serve as an 
appropriate measure of ROS level since our ER-stress paradigm has significant effects on 
mitochondrial bioenergetics.   
3.5.2 ER-stress induces mitochondrial superoxide production is 
independent of ATF4 upregulation  
To determine whether ATF4 expression affects mitochondrial superoxide production, 
WT and ATF4-deficient neurons were treated with TG and BSO, and superoxide 
production was assessed by MitoSOX™ Red. TG treatment increased the level of 
mitochondrial superoxide production, however, the superoxide levels did not differ 
between ATF4+/+ and ATF4-/- neurons (Figure 3.6). This suggests that ATF4 expression 
does not affect ER-stress induced oxidative processes. Furthermore, depletion of GSH 
using BSO in the absence of any stressors did not have an effect on mitochondrial 
superoxide levels.   
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Figure 3.5. TG treatment affects mitochondrial bioenergetics in an ATF4-
independent manner. PCN were extracted from E14.5-15.5 ATF4+/+ and ATF4-/- 
littermates and were plated in Seahorse XFe24 tissue culture microplates at a density of 
2.5×105 cells/well. Cells were incubated at 37˚C with 5% CO2 for 5 days prior to 
performing the assay. Cultures were treated with 1-µM TG for 12 hours and the Seahorse 
Mitostress test was performed to assess key parameters of mitochondrial function by 
directly measuring the OCR in each culture. The assay revealed that TG treatment has an 
impact on (a) basal respiration *p-value<0.05 and (b) ATP production *p-value<0.05 in 
both WT (n=3) and ATF4-deficient (n=3) neurons. (c) maximal respiration and 
consequently the (d) spare respiratory capacity are not significantly affected by the 
treatment. 
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Figure 3.6. Mitochondrial superoxide production is independent of ATF4 
upregulation. PCN were extracted from E14.5-15.5 ATF4+/+ and ATF4-/- littermates (a) 
and neurons were treated with BSO (100-µM) for 24 hours or with TG (1-µM) for 12 and 
24 hours. Cultures were then loaded with 0.2-µM MitoSOX Red for 2 hours to detect 
mitochondrial derived superoxide. Cells were also counter-stained with Hoechst 33342 
and the fluorescence of each field was normalized to the number of the cells in that field 
(b) quantification of MitoSOX Red fluorescence after normalization showed no 
difference between the two genotypes under any of the treatment conditions.   
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3.6 Endogenous ATF4 upregulation affects the gene 
expression profile of GSH related factors  
Since neither GSH regeneration capacity nor the extent of oxidative processes could 
account for why ATF4-deficient neurons are more efficient at maintaining GSH levels, or 
why WT cells lose GSH more rapidly when the de novo synthesis of GSH is blocked, we 
investigated various gene transcripts that are important for GSH degradation and 
synthesis. ChaC1 encodes glutathione-specific gamma-glutamylcyclotransferase 1, which 
is important for degradation of GSH. To measure transcript levels of this gene, cells were 
treated with TG for 8 hours and total RNA was isolated for performing qRT-PCR. 
Analysis of qRT-PCR results showed that ChaC1 is induced in WT (n=3) cells treated 
with TG but not ATF4-KO (n=3) neurons (*p<0.05) (Figure 3.7a). This finding suggests 
that WT neurons may degrade GSH more rapidly compared to the ATF4-KO, which 
might partly explain why the WT cells have lower levels of GSH compared to the ATF4-
deficient neurons after induction of prolonged ER-stress (Figure 3.3a).  
For GSH synthesis, we assessed the expression of two different transcripts: GCL, which 
catalyzes the rate limiting step in synthesis of GSH and SLC7A11, which encodes a 
cystine-glutamate antiporter, also known as system xc
-, which is important for the uptake 
of precursors for synthesis of GSH. Cultures were treated with TG for 8 hours, total RNA 
was isolated from the samples and transcript levels were measured using qRT-PCR. 
Results showed no difference in GCL mRNA level between WT (n=4) and ATF4-KO 
(n=4) neurons (Figure 3.7b). In fact, ER-stress did not have any effect on GCL transcript 
levels in neurons from either genotype. Interestingly, evaluation of SLC7A11 mRNA 
level showed an ATF4-dependent increase in neurons after treatment with TG (**p<0.01) 
(Figure 3.7c). This finding may suggest that even though WT cells might degrade GSH 
more rapidly, they compensate for it by increasing the rate of GSH synthesis. It also 
explains why the WT cells lose GSH more rapidly once de novo synthesis of GSH is 
inhibited. 
The mRNA level for each gene was also measured at baseline relative to S12 control in 
both WT and ATF4-deficient cells and was reported as ΔCt. Results suggested that ATF4 
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did not have an effect on basal mRNA levels of any of these glutathione related 
transcripts (Figure 3.7d, e, f).  
3.7 Replenishment of the antioxidant pool does not protect 
neurons against ER-stress-induced cell death  
In the previous report by Lange et al. (2008) it was shown that the cell death that result 
from ectopic overexpression of ATF4 can be ameliorated by treating cells with an 
antioxidant such as butylated hydroxyanisole (BHA). Therefore, we examined whether 
addition of antioxidants might be protective in an endogenous ATF4-dependent cell death 
paradigm. We performed a live/dead assay on neurons treated with TG (n=11), TG in 
combination with N-acetylcysteine (NAC) (n=11), which is an antioxidant and acts as a 
precursor for GSH synthesis, as well as TG in combination with BHA (n=9), which is 
another well-characterized antioxidant, for 30 hours. As shown in figure 3.8 (a, b), TG 
treatment reduced cell viability as expected (**p< 0.01). However, contrary to what was 
reported by Lange et al, following ectopic expression of ATF4, addition of antioxidants 
did not have a significant effect on cell viability in endogenous ATF4-dependent 
neuronal death (Figure 3.8a, b). Furthermore, the effect of each antioxidant alone was 
also examined on cell viability and it was confirmed that the concentrations used were 
not toxic to the cells (Figure 3.8 c, d).   
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Figure 3.7. ATF4 upregulation causes differential transcription of GSH-related 
genes. PCNs extracted from E14.5-15.5 ATF4+/+ and ATF4-/- littermates were treated 
with 1-µM TG for 8 hours and RNA was isolated using TRIzol® Reagent and the 
expression of glutathione related transcripts was assessed by qRT-PCR. Relative mRNA 
levels are reported as fold increase in TG treated neurons as compared to untreated 
neurons. (a) ChaC1 was induced in response to ER-stress in WT (n=3) neurons but not in 
ATF4-KO (n=3) cells (*p<0.05) (b) GCL mRNA level was not affected by ER-stress in 
WT (n=4) or ATF4-deficient (n=4) cells (c) SLC7A11 transcript was induced in WT 
(n=3) cells treated with TG but not in ATF4-deficient (n=3) neurons (**p<0.01). The * 
on each bar represents significance compared to untreated control (d,e,f) relative 
expression of each transcript was measured at the baseline in both WT and ATF4-
deficient neurons and was reported as ΔCt (Ct (GOI)- Ct (S12)). Results indicate that the 
mRNA levels of ChaC1, GCL, or SlC7A11 in untreated ATF4+/+ and ATF4-/- neurons is 
not significantly different. 
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Figure 3.8. Replenishment of the antioxidant pool does not protect neurons against 
cell death. PCN were extracted from E14.5-15.5 C57/BL6 embryos and were cultured at 
a density of 3×105 cells/well. Cells were treated as specified for 30 hours and were loaded 
with calcein-AM (1-µM) and ethidium homodimer-1 (3-µM) for 10 minutes. (a) 
Representative live/dead assay images showing untreated, TG treatment (1-μM) (n=11), 
TG (1-µM)+NAC (1-mM) (n=11) and TG (1-µM)+BHA (10-μM) (n=9). (b) 
quantification of all trials (n=11 for UT, TG, TG+NAC, n=9 for NAC+BHA). In any 
single trial, 4 different fields in each well were imaged under each filter. All four fields 
were counted and averaged to yield an n=1 **p-value<0.001 (c, d) treatment with BHA 
and NAC alone did not affect cell viability compared to control (n=3). 
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3.8 ATF4 protein levels can be upregulated/stabilized in the 
presence or absence of ISR  
The aim of this project was to investigate whether upregulation of endogenous ATF4 is 
sufficient to reduce GSH levels in neurons, and to identify key players in this process. 
Our findings demonstrate that unlike ectopically overexpressed ATF4, upregulation of 
endogenous ATF4 does not reduce GSH levels. To further investigate this differential 
observation, transcriptional activity of ATF4 was assessed after the protein was stabilized 
by different mechanisms in both N2As and primary cortical neurons (PCNs). Three 
different mechanisms were used to stabilize ATF4 protein in N2A cells, which included 
activation of ISR using TG treatment that allows for expression of ATF4 through post-
transcriptional modifications, inhibition of proteasome using MG132 treatment, which 
prevents degradation of ATF4 protein and stabilizes it post-translationally, and finally 
ectopic overexpression of the protein through plasmid transfection. In PCNs, a method to 
ectopically overexpress the protein was not available, but ATF4 was still stabilized using 
TG and MG132 treatments. Western blot analysis showed that all three mechanisms led 
to a significant increase in ATF4 protein levels, suggesting that the chosen mechanisms 
are effective in stabilizing ATF4 protein (Figure 3.9).  
3.9 Downstream target genes that are induced by ATF4 
differ, depending on how ATF4 is expressed or stabilized. 
After confirming that ATF4 protein is upregulated in response to different treatments, we 
performed a qRT-PCR to assess the expression of different downstream targets of ATF4 
including some known pro-apoptotic targets such as CHOP and Trib3, as well as other 
ones whose roles are still not fully understood such as ATF3 and 4E-BP1. Our results 
showed that when ATF4 was activated through the conventional ISR pathway, the ATF4-
regulated pro-apoptotic target genes, CHOP and Trib3 were more robustly induced 
compared to ectopically overexpressed ATF4 and post-translationally stabilized 
endogenous ATF4 in both N2As and PCNs (Figure 3.10). In contrast, ATF4 stabilized 
post-translationally using MG132 treatment induced the expression of ATF3 more 
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robustly than ISR-induced and ectopically overexpressed ATF4 in both N2A cells and 
PCNs (Figure 3.10). There are also other target genes such as 4E-BP1 that is induced in 
PCNs but not N2A cells (Figure 3.10). This further highlights a cell type dependent 
activity of ATF4 since some target genes are only induced in one cell-type but not 
another. Interestingly, we found that despite the high level of ATF4 expression observed 
in N2A cells transfected with pc-DNA3-mATF4 (Figure 3.9b), there was not a significant 
induction of any of these ATF4 target genes (Figure 3.10a). These results suggest that the 
downstream gene targets of ATF4 differ depending on the cells type and the context of 
ATF4 expression, which might partly explain the differential results observed in terms of 
its effect on GSH levels.  
Since we observed differences in the induction of known ATF4 target genes based on the 
context of ATF4 expression, we therefore assessed whether these differences persist in 
GSH related transcripts. We previously showed that ChaC1 and SlC7A11 are induced in 
WT neurons, when ATF4 is expressed through ISR activation (Figure 3.7a,c). We then 
measured the level of mRNA induction of these genes in N2A cells after stabilization of 
ATF4 post-transcriptionally through ISR, post translationally through proteasome 
inhibition, and also through ectopic overexpression using pcDNA3-mATF4. Our results 
showed that ISR-induced ATF4 (n=4) increases the expression of ChaC1 and SlC7A11 
mRNA more robustly than post-translationally stabilized ATF4 (n=5) (ChaC1: *p<0.05; 
SlC7A11: **p<0.01) (Figure 3.11). Furthermore, consistent with our previous data, 
ectopically overexpressed ATF4 (n=4), did not induce either of the GSH-related target 
genes (Figure 3.11). These data further highlight the importance of the context of ATF4 
expression in the induction of its downstream target genes and further confirm that the 
disparity between our observations in terms of GSH is due to the differential mode of 
ATF4 activation.   
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Figure 3.9. ATF4 protein levels are increased in response to various treatments. 
N2As and PCNs were treated with 1-µM TG or 10-µM MG132 for 8 hours. N2A cells 
were also transfected with pcDNA3-mATF4. Protein was extracted and immunoblotted 
for ATF4 and cyclophilin-B as a loading control. (a) Representative blots showing ATF4 
protein expression under described conditions in both N2A and PCNs (b) quantification 
of ATF4 upregulation in response to TG and MG132 treatments, and after plasmid 
overexpression in N2A cells (n=4) (c) quantification of ATF4 protein level following 
treatment with MG132 and TG in PCNs (n=5).   
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Figure 3.10. Downstream target genes that are induced by ATF4 differ, depending 
on the cell type and mechanism of ATF4 expression. N2As and PCNs were treated 
with 1-µM TG or 10-µM MG132 for 8 hours. N2A cells were also transfected with 
plasmid DNA expressing ATF4 (pcDNA3-mATF4). Total RNA was isolated and relative 
mRNA levels of the indicated transcripts was determined by qRT-PCR. (a) In N2A cells, 
TG treatment (n=5) induced CHOP and Trib3 to a greater extent as compared to MG132 
(n=5) (****p<0.0001, *p<0.05), and OE-ATF4 (n=4) (***p<0.001, *p<0.05), while the 
induction of ATF3 was more significant with MG132 compared to TG treatment 
(**p<0.01) and OE-ATF4 (**p<0.01). 4E-BP1 induction was not significant under any 
of the treatment conditions. (b) The trend of mRNA induction of the target genes in the 
cortical neurons also followed what was observed in N2As, with TG (n=3) inducing 
CHOP (*p<0.05) and Trib3, and MG132 (n=3) inducing ATF3 (****p<0.0001) more 
robustly.  
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Figure 3.11. The mechanism of ATF4 expression affects the induction of GSH 
related transcripts. N2A cells were treated with 1-µM TG or 10-µM MG132 for 8 
hours. Cells were also transfected with plasmid DNA expressing ATF4 (pcDNA3-
mATF4). Total RNA was isolated and relative mRNA levels of the indicated transcripts 
was determined by qRT-PCR. (a) TG treatment (n=4) induced ChaC1 significantly more 
compared to MG132 treatment (n=5) (*p<0.05) and overexpressed ATF4 (n=4) 
(**p<0.01). (b) TG treatment (n=4) also induced a more robust expression of SlC7A11 
compared to MG132 treatment (n=5) (**p<0.01) as well as overexpressed ATF4 (n=4) 
(***p<0.001). * above each bar indicates significance compared to control.    
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Chapter 4  
 
4 Discussion  
4.1 ATF4 plays a role in GSH synthesis  
ATF4 is a bZIP transcription factor that is induced in response to various cell stressors 
such as oxidative and ER-stress as part of the integrated stress response (ISR). Although 
initially, induction of ATF4 acts to alleviate stress, prolonged activation of ATF4 has 
been shown to be pro-apoptotic in neurons and other cell types (Harding et al, 2003, 
Lange et al, 2008; Galehdar et al, 2010). ATF4 can promote cell death through the 
transcriptional induction of pro-apoptotic factors such as CHOP and Trib3 (Galehdar et 
al, Aimé et al, 2015). However, there is also evidence suggesting that ectopic 
overexpression of ATF4 in primary cortical neurons can lead to depletion of cellular 
GSH levels, which is an important antioxidant (Lange et al, 2008). Interestingly, the same 
report suggested that cell death caused by overexpression of ATF4 could be ameliorated 
by the addition of antioxidants, suggesting that the observed cell death is a consequence 
of GSH depletion (Lange et al, 2008). Consistent with this, we have previously 
demonstrated that depletion of GSH can sensitize neurons to oxidative stress-induced cell 
death (Baxter et al, 2015). In this project, an ATF4-dependent cell death paradigm was 
used to examine whether GSH depletion and oxidative stress are also consequents of 
endogenously upregulated ATF4. To address this, WT and ATF4-deficient neurons were 
treated with thapsigargin (TG), which is an ER-stressor and an activator of the integrated 
stress response (ISR) that we have previously shown to induce neuronal cell death in an 
ATF4-dependent manner. After a prolonged period of ER-stress, glutathione (GSH) 
levels were measured in these cells. The results showed that unlike ectopically 
overexpressed ATF4, endogenous upregulation of ATF4 through activation of the ISR 
enabled WT cells to maintain higher levels of GSH than ATF4-deficient neurons (Figure 
3.2). Intracellular GSH levels are regulated through three main mechanisms: synthesis, 
utilization and regeneration.  To determine which part of the GSH pathway was affected 
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by ATF4 expression, neurons were treated with TG, while de novo synthesis of GSH was 
blocked using BSO, which inhibits glutamylcysteine ligase (GCL), an enzyme that 
catalyzes the rate limiting step in GSH synthesis. Therefore, inhibition of GSH synthesis 
using BSO, allows for indirect measurement of the other two mechanisms, regeneration 
ad utilization. This way, we control for possible differential rates of synthesis and only 
measure the GSH reserve as well as regenerated GSH in the cultures. Interestingly, our 
results showed that when GSH synthesis is inhibited under stress conditions, WT neurons 
lost GSH more rapidly than ATF4-deficient neurons (Figure 3.3a); an opposite trend to 
what was observed in the absence of the GCL inhibitor. Taken together, these results 
suggest that endogenous ATF4 upregulation leads to a more rapid loss of GSH in neurons 
but compensates for this by increasing the rate of GSH synthesis.  
As mentioned earlier, indirect measurement of regenerated and reserved GSH indicated 
that WT cells have lower levels compared to ATF4-deficient neurons (Figure 3.3a). To 
further narrow down the part of the pathway affected by ATF4, we first assessed whether 
the obtained results were due to a differential rate of GSH regeneration by measuring the 
levels of various key players in the pathway including glutathione reductase (GR) activity 
and gene transcript levels as well as NADPH concentrations. GR is the enzyme 
responsible for regeneration of reduced GSH from its oxidized form, GSSG, and it uses 
NADPH as a precursor in this process (Maher, 2005). GSH regeneration is important 
since decreased GSH: GSSG ratio has been associated with oxidative stress and has been 
seen in post mortem brain of patients with AD and PD (Ballatori, Krance, Notenboom, 
Shi, Tieu & Hammond, 2009; Ansari & Scheff, 2010; Dexter et al, 1994; Sian et al, 
1994). Initially, we attempted to directly measure GR activity as well as GSH: GSSG 
ratio, however, due to high variability and low sensitivity of the assays, our efforts were 
mainly unsuccessful. Therefore, instead of direct measurement of GR activity, we 
measured GR transcript levels as a corelate of its activity, even though this poses 
limitations for interpretation of the data. Our qRT-PCR results showed that ER-stress 
caused a reduction in GR mRNA but that this was not dependent on ATF4 (Figure 3.4a). 
The fact that GR transcript levels are decreased under ER-stress condition is surprising 
considering that under these conditions, oxidative processes in the cells are increased 
(Figure 3.6) and the cells utilize GSH more rapidly (Figure 3.2) and hence require an 
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efficient regeneration capacity in order to maintain physiologic GSH: GSSG ratio. 
Measurement of NADPH levels, in ATF4+/+ and ATF4-/- cortical neuron cultures also 
showed that ER-stress decreased NADPH in an ATF4-independent manner (Figure 3.4c). 
The main source of intracellular NADPH is the pentose phosphate pathway (PPP) 
(Maher, 2005). It has been shown that shunting of the glucose away from the PPP in 
neurons leads to rapid neuronal apoptosis (Herrero-Mendez, Almeida, Fernández, 
Maestre, Moncada & Bolaños, 2009). The reduction of NADPH levels in the presence of 
ER-stress might imply the involvement of the ER-stress in downregulation of the PPP 
and possibly shunting of the glucose away from the PPP. Furthermore, lower levels of 
NADPH in the presence of ER-stress might also reflect that more NADPH is being used 
for regeneration, in order to maintain the GSH pool in neurons. Together, these results 
showed that ATF4 does not affect GSH regeneration. 
An alternative explanation as to why WT cells lose GSH more rapidly could be that the 
WT cells utilize more GSH due to higher oxidative processes. We chose to look at 
mitochondrial superoxide levels as a measure of ROS in the cells. To confirm that TG 
treatment affects the mitochondrial bioenergetics, we analyzed different mitochondrial 
parameters by measuring the oxygen consumption rate (OCR) of neurons using Seahorse 
Mito Stress test under different treatment conditions. Results showed that certain 
mitochondrial aspects such as basal respiration and ATP production are affected by TG 
(Figure 3.5), suggesting that mitochondrial superoxide is an appropriate measure for 
oxidative processes in this paradigm. After assessing mitochondrial superoxide levels in 
both WT and ATF4-deficient neurons at baseline and after treatment with TG for 12 and 
24 hours, we saw that even though TG treatment seems to be increasing mitochondrial 
superoxide levels, there are no ATF4-dependent differences under any of the treatment 
conditions (Figure 3.6). While mitochondrial superoxide seems to be an appropriate 
measure for ROS production in an ER-stress paradigm, it is possible that other forms of 
ROS that were not considered are affected by ATF4. Furthermore, it would also be 
interesting to measure other free radicals that are directly affected by GSH, such as 
hydroxyl radicals in both WT and ATF4-deficient cultures (Maher, 2005). Taken 
together, none of these efforts provided an explanation as to why upregulation of ATF4 
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leads to a more rapid reduction of GSH in WT neurons compared to ATF4-KO cells 
when GSH synthesis is inhibited in both cultures. 
To further investigate this, we measured transcript levels of various GSH related genes 
including ChaC1, GCL and SlC7A11. ChaC1 protein is important for degrading GSH 
(Crawford et al, 2015). Analyses of qRT-PCR results showed that ChaC1 is induced in 
WT cells treated with TG but not ATF4-KO neurons (Figure 3.7a). This finding suggests 
that WT neurons possibly degrade GSH more rapidly compared to ATF4-KO cells. This 
might explain why WT cells lose GSH more rapidly compared to ATF4-KO neurons 
when the de novo synthesis of GSH is blocked using BSO (Figure 3.3a). As mentioned 
earlier, the pattern of GSH loss is reversed in the absence of BSO, suggesting that there is 
compensatory mechanism through synthesis in the WT cells. We measured 2 different 
gene transcripts that are important for GSH synthesis: GCL and SlC7A11. GCL is the 
enzyme responsible for catalyzing the first step of GSH synthesis: linkage of glutamate 
and cysteine to produce γ-glutamylcysteine. Our results showed that ER-stress had no 
effect on GCL mRNA levels. SlC7A11 is an important component of system xc
-, which is 
a cystine/glutamate antiporter and is important for GSH synthesis since cysteine is the 
limiting precursor in the process and so the expression of the antiporter is important for 
maintaining GSH levels (Clemons, Liu, Duong & Phillips, 2017). Recently it has been 
reported that SlC7A11 is induced in response to glucose starvation, through the activity 
of ATF4 (Koppula, Zhang, Shi, Li & Gan, 2017). In line with these results, our qRT-PCR 
data showed that SlC7A11 is induced under ER-stress conditions but only in the WT cells 
(Figure 3.7c), highlighting the importance of ATF4 for induction of this gene. Therefore, 
the induction of this gene might be the mechanism by which the WT cells increase the 
rate of their GSH synthesis and compensate for the GSH loss caused by ChaC1.  
4.2 ATF4-dependent cell death under ER-stress conditions 
is independent of antioxidant depletion  
In a previous report by Lange et al (2008), it was shown that that the cell death that is 
seen as a result of ectopic ATF4 overexpression can be ameliorated by treating cells with 
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an antioxidant such as BHA, suggesting that the ATF4-dependent cell death is due to 
antioxidant depletion. Therefore, we next examined whether ATF4-dependent cell death 
observed in an ER-stress paradigm can be alleviated by addition of antioxidants to the 
culture. Our results showed that addition of antioxidants such as NAC and BHA had no 
effect on cell viability and it did not protect neurons against ER-stress -induced, cell 
death (Figure 3.8 a,b). Although the compounds used in these experiments are well-
documented antioxidants and to reduce oxidative damage in the cells (Aldini et al, 2018; 
Lam, Pai & Wattenberg, 1979), it will be important for future experiments to confirm that 
they effectively reduce oxidative processes in our paradigm.  
4.3 ATF4 induces different target genes depending on how 
it’s stabilized/ expressed  
The next step was to find an explanation for the differential observations regarding the 
effects of ectopically overexpressed and endogenously upregulated ATF4 on cellular 
GSH levels. ATF4 is a bZIP transcription factor, which functions as a heterodimer with 
other bZIP family transcription factors. It has been shown that different 
heterodimerization partners can influence the outcome of ATF4 activation (Wang et al, 
2009; Ohoka, Yoshii, Hattori, Onozaki & Hayashi, 2005; Huggins et al, 2016). 
Therefore, ATF4 was stabilized/expressed in 3 different ways in order to assess whether 
it will have an effect on its transcription of downstream gene targets. The three different 
ways of expression/stabilization were post-transcriptional modification through the 
activation of the ISR, post-translational stabilization through inhibition of the proteasome 
(Milani et al, 2009) and finally ectopic overexpression through plasmid transfection. 
Analysis of qRT-PCR results showed that indeed the mechanism by which ATF4 is 
expressed plays a role in differential induction of target genes including GSH related 
transcripts. For example, our results showed that pro-apoptotic genes such as CHOP and 
Trib3 are induced when ATF4 is expressed in response to ISR, while ATF3 is induced 
more robustly when ATF4 is stabilized post-translationally (Figure 3.10). Similarly, 
ChaC1 and SlC7A11 are also induced more robustly in the presence of ISR-activated 
ATF4 than post-translationally stabilized or overexpressed form of the protein (Figure 
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3.11). Furthermore, there are other genes such as 4E-BP1 that is induced in primary 
cortical neurons but not in N2A cells, suggesting that ATF4 can regulate target genes in a 
cell-type specific manner (Figure 3.10). Consistent with this, comparison of ATF4 gene 
expression array data in neurons and fibroblasts has shown that while there is significant 
overlap in the expression profiles, there is a subset of genes that is regulated in neurons 
but not in fibroblasts (Lange et al, 2008). This confirms that although ATF4 regulates 
most of its target genes in a cell type-independent manner, certain genes such as Trib3 are 
regulated in a cell-type specific manner. This could also party explain why ATF4 plays a 
pro-survival role in some cells and a pro-apoptotic role in others. In our results, it is likely 
that the differences seen in the pattern of target gene induction would be due to 
interaction of ATF4 with different dimerization partners that differ based on how ATF4 
is expressed. Furthermore, considering that ectopic overexpression of ATF4 elevated 
protein levels of ATF4 substantially, it seems that it is ineffective in terms of target gene 
induction since none of the transcripts were induced in response to plasmid 
overexpression. This suggest that stress might be an important aspect for proper 
heterodimerization, activation and consequently function of ATF4. Unfortunately, in this 
study we did not have access to viral vector to ectopically express ATF4 in primary 
neuronal cultures as in would be interesting to determine whether enforced expression of 
ATF4 in primary neurons is also inefficient in driving target gene transcription. These 
results may partly explain the differential observations regarding GSH metabolism in 
neurons.  
Additionally, the model used in the study published by Lange and colleagues (2008), 
employed immature cortical neurons while in our study, we ensured that neurons are 
matured in culture before conducting any experiments so that our interpretations were 
more reflective of how mature neurons respond and react to upregulation of ATF4 
expression. It is possible that the maturity level of neurons would affect the activity of 
ATF4 protein or how neurons respond to ATF4 protein induction. 
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Chapter 5  
5 Conclusion  
ATF4 has been shown to act as a proapoptotic transcription factor in neurons, however 
the mechanism by which ATF4 promotes neuronal cell death remains unclear. A previous 
study suggested that in an overexpression paradigm, ATF4 can promote neuronal cell 
death by decreasing cellular GSH, leading to oxidative stress-induced apoptosis. In 
contrast, we found that endogenous upregulation of ATF4 under cell stress conditions 
promote GSH synthesis and functions to maintain cellular GSH levels. Furthermore, we 
found that ATF4-dependent cell death induced by ER-stress is not correlated with GSH 
levels and cannot be ameliorated through replenishment of the cellular antioxidant pool. 
Taken together, our results suggest that oxidative stress is more likely a causative factor 
in ATF4 activation as opposed to a consequence. Finally, we suggest that the underlying 
reason behind the disparity in observations in terms of the effect of ATF4 on GSH levels, 
may be due to induction of different target genes and possibly different ATF4 
heterodimerization partners.   
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Appendix A. NADPH reaction mix  
Reagent Standards and 
Samples 
NADPH Cycling 
Buffer 
97µL 
NADPH Cycling 
Enzyme Mix 
2 µL 
High-sensitivity Probe 1 µL 
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Forward Sequence Reverse Sequence 
4eBP1 GGGGACTACAGCACCACTC GTTCCGACACTCCATCAGAAAT 
ATF3 CCCCTGGAGATGTCAGTCAC GCAGGCACTCTGTCTTCTCC 
ChaC1 ACAAGATGCCTGGCCGAGTG AGGTACTTCAGGGCCTCGTT 
CHOP ACAGAGGTCACACGCACATC GGGCAGTGACCACTCTGTTT 
GADD45 CTGCTGCTACTGGAGAACGAC CGACTTTCCCGGCAAAAACAAA 
GCL TGGGCACAGGTAAAACCCAA CTGGGCTTCAATGTCAGGGA 
GR TGGCACTTGCGTGAATGTTG CGAATGTTGCATAGCCGTGG 
S12 GGAAGGCATAGCTGCTGG CCTCGATGACATCCTTGG 
SlC7A11 TTTGGAGCCCTGTCCTATGC GCTCCAGGGCGTATTACGAG 
Trib3 TGCAGGAAGAAACCGTTGGAG CTCGTTTTAGGACTGGACACTT 
Appendix B. qRT-PCR primer list  
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